Picture Berlin Partner Bionnale 2023 the Life Sciences Event 650x100px
Collaboration › Details

Bruker–SVB: investor conference, 202102 supply service Bruker presents at SVB Leerink Global Healthcare Conference


Period Period 2021-02-25
Organisations Partner, 1st Bruker Corporation (Nasdaq: BRKR)
  Group Bruker (Group)
  Partner, 2nd SVB Leerink LLC
  Today SVB Securities LLC
Products Product SVB Leerink Annual Global Healthcare Conference 2021 DIGITAL
  Product 2 analytical instrument
Persons Person Laukien, Frank H. (Bruker 201204 President + CEO)
  Person 2 Minkova, Miroslava (Bruker Corp 201611 Head of Investor Relations)

Bruker Corporation. (2/22/21). "Press Release: Bruker Corporation to Present at Investor Conferences". Billerica, MA.

Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the following virtual conferences:

10th Annual SVB Leerink Healthcare Conference

Thursday, February 25, 2021, at 8:40 a.m. Eastern Time
Frank Laukien, Chairman, President and Chief Executive Officer

Cowen 41st Annual Health Care Conference

Tuesday, March 2, 2021, at 11:10 a.m. Eastern Time
Gerald Herman, Chief Financial Officer

Live audio webcasts of the virtual “fireside chat” sessions will be available on the Investor Relations section of the Company's website at Replays will be posted on Bruker’s Investor Relations website after each event and will be available for 30 days following the presentation.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit:

Miroslava Minkova
Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479

Record changed: 2022-01-02


Picture [iito] [LSE] Business Portal 650x200px

More documents for Bruker (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Berlin Partner Bionnale 2023 the Life Sciences Event 650x300px

» top